Abstract
Migraine is a complex genetic brain disorder with an intricate pathogenesis and polymorphous clinical presentations, particularly in children. In this Perspective, we describe the different phenotypes of migraine in children, including conditions that have been referred to in the International Classification of Headache Disorders as “syndromes that may be related to migraine’’. Evidence is presented for the integration of abdominal migraine, cyclical vomiting syndrome, benign paroxysmal vertigo, benign paroxysmal torticollis and infantile colic into the unified diagnosis of ‘childhood migraine syndrome’ on the basis of clinical and epidemiological characteristics, and shared inheritance. In our opinion, such integration will guide clinicians from specialities other than neurology to consider migraine in the assessment of children with these disorders, as well as stimulate research into the genetics, pathophysiology and clinical features of all disorders within the syndrome. A diagnosis of childhood migraine syndrome would also enable patients to benefit from inclusion in clinical trials of old and new migraine treatments, thus potentially increasing the number of treatment options available.
Similar content being viewed by others
References
Isler, H. & Koehler, P. J. in The Headaches (eds Olesen, J., Goadsby, P. J., Ramadan, N., Tfelt-Hansen, P. & Welch, K. M.) 1–7 (Lippincott Williams & Wilkins, 2006).
Williams, A. N. in Childhood Headache (ed. Abu-Arafeh, I.). 4–14 (Mac Keith Press, 2013).
Headache Classification Committee of the International Headache Society (HIS). The international classification of headache disorders, 3rd edition. Cephalalgia 38, 1–211 (2018).
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 8 (Suppl. 7), 9–96 (1988).
Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia. 24, 8–160 (2004).
Özge, A. et al. Experts’ opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents. J. Headache Pain 18, 109 (2017).
Özge, A. et al. Experts’ opinion about the secondary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents. J. Headache Pain 18, 113 (2017).
Tarantino, S. et al. Migraine equivalents as part of migraine syndrome in childhood. Pediatr. Neurol. 51, 645–649 (2014).
Farlex. Syndrome. The free dictionary. https://medical-dictionary.thefreedictionary.com/syndrome (2012).
Blumenthal, H. J. & Rapoport, A. M. The clinical spectrum of migraine. Med. Clin. North Am. 85, 897–909 (2001).
Giffin, N. J., Benton, S. & Goadsby, P. J. Benign paroxysmal torticollis in infancy: four new cases and linkage to CACNA1A mutation. Dev. Med. Child. Neurol. 44, 490–493 (2002).
Abu-Arafeh, I., Razak, S., Sivaraman, B. & Graham, C. The prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev. Med. Child. Neurol. 52, 1088–1097 (2010).
Wöber-Bingöl, C. Epidemiology of migraine and headache in children and adolescents. Curr. Pain Headache Rep. 17, 341 (2013).
Russell, M. B. & Olesen, J. Increased familial risk and evidence of genetic factor in migraine. BMJ 311, 541–544 (1995).
Russell, M. B., Iselius, L. & Olesen, J. Migraine without aura and migraine with aura are inherited disorders. Cephalalgia 16, 305–309 (1996).
Neut, D., Fily, A., Cuvellier, J.-C. & Vallee, L. The prevalence of trigger factors in paediatric migraine: a questionnaire study in 102 children and adolescents. J. Headache Pain 13, 61–65 (2012).
Ophoff, R. A. et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87, 543–552 (1996).
Costa, C. et al. A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. Cephalalgia. 34, 68–72 (2014).
Coppola, G., Pastorino, G. M. G., Vetri, L., D’Onofrio, F. & Operto, F. F. Familial hemiplegic migraine with ATP1A4 mutation: clinical spectrum and carbamazepine efficacy. Brain Sci. 18, 372 (2020).
Castro, M. J. et al. First mutation in the voltage-gated Nav1.1 subunit gene SCN1A with co-occurring familial hemiplegic migraine and epilepsy. Cephalalgia. 29, 308–313 (2009).
Stendel, C. et al. Association of a novel splice site mutation in P/Q-type calcium channels with childhood epilepsy and late-onset slowly progressive non-episodic cerebellar ataxia. Int. J. Mol. Sci. 21, 3810 (2020).
Zhuchenko, O. et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nat. Genet. 15, 62–69 (1997).
Gormley, P. et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat. Genet. 48, 856–866 (2016).
Cuenca-Leon, E. et al. Genetic analysis of 27 Spanish patients with hemiplegic migraine, basilar-type migraine and childhood periodic syndrome. Cephalalgia 28, 1039–1047 (2008).
Burstein, R., Noseda, R. & Borsook, D. Migraine: multiple processes, complex pathophysiology. J. Neurosci. 35, 6619–6629 (2015).
Goadsby, P. J. et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol. Rev. 97, 553–622 (2017).
Buzzi, M. G. & Moskowitz, M. A. The pathogenesis of migraine: year 2005. J. Headache Pain 6, 105–111 (2005).
Messina, R., Filippi, M. & Goadsby, P. J. Recent advances in headache neuroimaging. Curr. Opin. Neurol. 31, 379–385 (2018).
Ferrari, M. D., Roon, K. I., Lipton, R. B. & Goadsby, P. J. Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358, 1668–1675 (2001).
Olesen, J. et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N. Engl. J. Med. 11, 1104–1110 (2004).
Schlute, L. H. & May, A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain 139, 1987–1993 (2016).
Barbanti, P. et al. Dopaminergic symptoms in migraine: a cross-sectional study on 1148 consecutive headache center-based patients. Cephalalgia 40, 1168–1176 (2020).
Tfelt-Hansen, P. C. History of migraine aura and cortical spreading depression from 1941 and onwards. Cephalalgia 30, 780–792 (2010).
Puledda, F., Ffytche, D., O’Daly, O. & Goadsby, P. J. Imaging the visual network in the migraine spectrum. Front. Neurol. 10, 1325 (2019).
Burke, M. J. et al. Mapping migraine to a common brain network. Brain 143, 541–553 (2020).
Wei, H. L. et al. Impaired effective functional connectivity of the sensorimotor network in interictal episodic migraineurs without aura. J. Headache Pain 21, 111 (2020).
Bolay, H. Thalamocortical network interruption: a fresh view for migraine symptoms. Turk. J. Med. Sci. 50, 1651–1654 (2020).
Fliatova, E., Latysheva, N. & Kurenkov, A. Evidence of persistent central sensitisation in chronic headache: a multi-method study. J. Headache Pain 9, 295–300 (2008).
Bigal, M. E. et al. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 70, 1525–1533 (2008).
Lahat, E. et al. Visual evoked potentials: a diagnostic test for migraine in children. Dev. Med. Child. Neurol. 39, 85–87 (1997).
Mortimer, M. J. & Good, P. A. The VER as a diagnostic marker for childhood abdominal migraine. Headache 30, 642–645 (1990).
Richer, L. et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst. Rev. 4, CD005220 (2016).
Edvinsson, L., Haanes, K. A., Warfvinge, K. & Krause, D. N. CGRP as the target of new migraine therapies – successful translation from bench to clinic. Nat. Rev. Neurol. 14, 338–350 (2018).
Deng, H. et al. Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – an updated systematic review and meta-analysis. BMC Neurol. 20, 57 (2020).
Zarcone, D. & Corbetta, S. Shared mechanisms of migraine, epilepsy and affective disorders. Neurol. Sci. 38, 73–76 (2017).
Breslau, N., Davis, G. C., Schultz, L. R. & Peterson, E. L. Joint 1994 Wolff award presentation. Migraine and major depression: a longitudinal study. Headache 34, 387–393 (1994).
Breslau, N. et al. Headache and major depression: is the association specific to migraine? Neurology 54, 308–313 (2000).
Aromaa, M., Rautava, P., Helenius, H. & Sillanpää, M. L. Factors of early life as predictors of headache in children at school entry. Headache 38, 23–30 (1998).
Milde-Busch, A. et al. Association between stress and migraine and tension-type headache: results from a school-based study in adolescents from grammar schools in Germany. Cephalalgia 31, 774–785 (2011).
Abu-Arafeh, I. & Russell, G. Prevalence of headache and migraine in schoolchildren. BMJ 309, 765–769 (1994).
Lipton, R. B. et al. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache 51, 693–706 (2011).
Ozge, A. et al. The prevalence of episodic and chronic migraine in children and adolescents. Eur. J. Neurol. 20, 95–101 (2013).
Wober-Bingol, C. et al. Clinical features of migraine: a cross-sectional study in patients aged three to sixty-nine. Cephalalgia 24, 12–17 (2004).
Ozge, A. et al. The sensitivity and specificity of the case definition criteria in diagnosis of headache: a school-based epidemiological study of 5562 children in Mersin. Cephalalgia 23, 138–145 (2003).
Solotareff, L., Cuvellier, J.-C., Duhamel, A., Vallee, L. & Tich, S. N. T. Trigger factors in childhood migraine: a prospective clinic-based study from North of France. J. Child. Neurol. 32, 754–758 (2017).
Kienbacher, C. et al. Clinical features, classification and prognosis of migraine and tension-type headache in children and adolescents: a long-term follow up study. Cephalalgia 26, 820–830 (2006).
Abu-Arafeh, I. & Callaghan, M. Short migraine attacks less than 2 h duration in children and adolescents. Cephalalgia 24, 333–338 (2004).
Powers, S. W. et al. The Childhood and Adolescent Migraine Prevention (CHAMP) study: a report on baseline characteristics of participants. Headache 56, 859–870 (2016).
Kober, J., Nyari, T., Benedek, G. & Turi, S. Age-related prevalence and features of migraine headache in Hungarian schoolchildren and adolescents. Eur. J. Paediatr. Neurol. 17, 600–607 (2013).
Ahmed, M., Boyd, C., Vavilikolanu, R. & Rafique, B. Visual symptoms and childhood migraine: qualitative analysis of duration, location, spread, mobility, colour and pattern. Cephalalgia 38, 2017–2025 (2018).
Quarshie, V. in Childhood Headache (ed. Abu-Arafeh, I.) 308–317 (Mac Keith Press, 2013).
Yamanaka, G. et al. Clinical features and burden scores in Japanese pediatric migraines with brainstem aura, hemiplegic migraine, and retinal migraine. J. Child. Neurol. 35, 667–673 (2020).
Taga, A. et al. Pediatric migraine with aura in an Italian case series. Neurol. Sci. 38, 185–187 (2017).
Smith, R. A., Wright, B. & Bennett, S. Hallucinations and illusions in migraine in children and the Alice in Wonderland syndrome. Arch. Dis. Child. 100, 296–298 (2015).
Mastria, G. et al. Prevalence and characteristics of Alice in Wonderland Syndrome in adult migraineurs: perspectives from a tertiary referral headache unit. Cephalalgia 41, 515–524 (2020).
Paemeleire, K. et al. Diagnosis, pathophysiology and management of chronic migraine: a proposal of the Belgian Headache Society. Acta Neurol. Belg. 115, 1–17 (2015).
Filippi, M. & Messina, R. The chronic migraine brain: what have we learned from neuroimaging. Front. Neurol. 10, 1356 (2019).
Chen, Z., Chen, X., Lui, M., Ma, L. & Yu, S. Volume of hypothalamus as a diagnostic biomarker of chronic migraine. Front. Neurol. 10, 606 (2019).
Coppola, G. et al. Cerebral gray matter volume in patients with chronic migraine: correlations with clinical features. J. Headache Pain 18, 115 (2017).
Bilgic, B. et al. Volumatic differences suggest involvement of cerebellum and brainstem in chronic migraine. Cephalalgia 36, 301–308 (2016).
Schwedt, T. J. et al. Atypical resting state functional connectivity of affective pain regions in chronic migraine. Headache 53, 737–751 (2013).
Welch, K. M., Nagesh, V., Aurora, S. K. & Gelman, N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41, 629–637 (2001).
Kruit, M. C., Launer, L. J., Overbosch, J., van Buchem, M. A. & Ferrari, M. D. Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia 29, 351–359 (2009).
Vivero, C. D. et al. Iron deposits in periaqueductal gray matter are associated with poor response to OnabotulinumtoxinA in chronic migraine. Toxins 12, 479 (2020).
Wessel, M. A., Cobb, J. C., Jackson, E. B., Harris, G. S. Jr. & Detwiler, A. C. Paroxysmal fussing in infancy, sometimes called colic. Pediatrics 14, 421–435 (1954).
Ellwood, J., Draper-Rodi, J. & Carnes, D. Comparison of common interventions for the treatment of infantile colic: a systematic review of reviews and guideline. BMJ Open 10, e035405 (2020).
Wolke, D., Bilgin, A. & Samara, M. Systematic review and meta-analysis: fussing and crying durations and prevalence of colic in infants. J. Pediatr. 185, 55–61 (2017).
Sillanpaa, M. & Saarinen, M. Infantile colic associated with childhood migraine: a prospective cohort study. Cephalalgia 35, 1246–1251 (2015).
Romanello, S. et al. Association between childhood migraine and history of infantile colic. JAMA 309, 1607–1612 (2013).
Jan, M. M. S. & Al-Buhairi, A. R. Is infantile colic a migraine-related phenomenon? Clin. Pediatrics 40, 295–297 (2001).
Gelfand, A. A., Thomas, K. C. & Goadsby, P. J. Before the headache, infantile colic as an early life expression of migraine. Neurology 79, 1392–1396 (2012).
Gelfand, A. A. et al. Association between parental migraine and infant colic: a cross sectional, web-based, US survey study. Headache 59, 988–1001 (2019).
Al-Twaijri, W. A. & Shevell, M. I. Pediatric migraine equivalents: occurrence and clinical features in practice. Pediatr. Neurol. 26, 365–368 (2002).
Hadjipanayis, A., Efstathiou, E. & Neubauer, D. Benign paroxysmal torticollis of infancy: an underdiagnosed condition. J. Paediatr. Child. Health 51, 674–678 (2015).
Rosman, N. P., Douglas, L. M., Sharif, U. & Paolini, J. The neurology of benign paroxysmal torticollis of infancy: report of 10 new cases and review of the literature. J. Child. Neurol. 24, 155–160 (2009).
Moavero, R. et al. Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: a longitudinal study. Cephalalgia 39, 1236–1240 (2019).
Danielsson, A. et al. Benign paroxysmal torticollis of infancy does not lead to neurological sequelae. Dev. Med. Child. Neurol. 60, 1251–1255 (2018).
Brodsky, J., Kaur, K., Shoshany, T., Lipson, S. & Zhou, G. Benign paroxysmal migraine variants of infancy and childhood: transition and clinical features. Eur. J. Pediatr. Neurol. 22, 667–673 (2018).
Greene, K. A. et al. Benign paroxysmal torticollis: phenotype, natural history, and quality of life. Pediatr. Res. https://doi.org/10.1038/s41390-020-01309-1 (2021).
Shin, M., Douglas, L. M., Milunsky, J. M. & Rosman, P. The genetics of benign paroxysmal torticollis of infancy; is there an association with mutations in CACNA1A gene? J. Child. Neurol. 31, 1057–1061 (2016).
Campbell, D. B., North, J. B. & Hess, E. J. Tottering mouse motor dysfunction is abolished on the Purkinji cell degeneration (PCD) mutant background. Exp. Neurol. 160, 268–278 (1999).
Dale, R. C., Gardiner, A., Antony, J. & Houlden, H. Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine. Dev. Med. Child. Neurol. 54, 958–960 (2012).
Krams, B., Echenne, B., Leydet, J., Rivier, F. & Roubertie, A. Benign paroxysmal vertigo of childhood: long-term outcome. Cephalalgia 31, 439–443 (2011).
Ralli, G., Atturo, F. & de Filippis, C. Idiopathic benign paroxysmal vertigo in children, a migraine precursor. Int. J. Pediatr. Otorhinolaryngol. 73, S16–S18 (2009).
Batuecas-Caletro, A. et al. Is benign paroxysmal vertigo of childhood a migraine precursor? Eur. J. Pediatr. Neurol. 17, 397–400 (2013).
Lindskog, U., Odkvist, L., Noaksson, L. & Wallquist, J. Benign paroxysmal vertigo in childhood: a long-term follow up. Headache 39, 33–37 (1999).
Abu-Arafeh, I. & Russell, G. Paroxysmal vertigo as a migraine equivalent in children: a population-based study. Cephalalgia 15, 22–25 (1995).
Kovacic, K., Sood, M. & Venkatesan, T. Cyclic vomiting syndrome in children and adults: what is new in 2018? Curr. Gastroenterol. Rep. 20, 46 (2018).
Abu-Arafeh, I. & Russell, G. Cyclical vomiting syndrome in children: a population-based study. J. Pediatr. Gastroenerol. Nutr. 21, 454–458 (1995).
Ertekin, V., Selimoglu, M. A. & Altnkaynak, S. Prevalence of cyclic vomiting syndrome in a sample of Turkish school children in an urban area. J. Clin. Gastroenterol. 40, 896–898 (2006).
Sagar, R. C. et al. Cyclic vomiting syndrome is a prevalent and under-recognised condition in the gastroenterology outpatient clinic. Neurogastroenterol. Motil. 30, e13174 (2018).
Drumm, B. R. et al. Cyclical vomiting syndrome in children: a prospective study. Neurogastroenterol. Motil. 24, 922–927 (2012).
Li, B. U. et al. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition consensus statement on diagnosis and management of cyclic vomiting syndrome. J. Pediatr. Gastroenerol. Nutr. 47, 379–393 (2008).
Saps, M., Nichols-Vinueza, D., Rosen, J. M. & Velasco-Benitez, C. A. Prevalence of functional gastrointestinal disorders in Colombian school children. J. Pediatr. 164, 542–545 (2014).
Abu-Arafeh, I. & Russell, G. Prevalence and clinical features of abdominal migraine compared with those of migraine headache. Arch. Dis. Child. 72, 413–417 (1995).
Mortimer, M. J., Kay, J. & Jaron, A. Clinical epidemiology of childhood abdominal migraine in an urban general practice. Dev. Med. Child. Neurol. 35, 243–248 (1993).
Dignan, F., Abu-Arafeh, I. & Russell, G. The prognosis of childhood abdominal migraine. Arch. Dis. Child. 84, 415–418 (2001).
D’Onofrio, F. et al. Adult abdominal migraine: a new syndrome or sporadic feature of migraine headache? A case report. Eur. J. Neurol. 13, 85–88 (2006).
Symon, D. N. & Russell, G. Abdominal migraine: a childhood syndrome defined. Cephalalgia 6, 223–228 (1986).
Hejazi, R. A. et al. Autonomic nerve function in adult patients with cyclic vomiting syndrome. Neurogastroenterol. Motil. 23, 439–443 (2011).
Kovacic, K. & Li, B. U. K. Cyclic vomiting syndrome: a narrative review and guide to management. Headache 61, 231–243 (2021).
Chelimsky, T. C. & Chelimsky, G. G. Autonomic abnormalities in cyclic vomiting syndrome. J. Pediatr. Gastroenterol. Nutr 44, 326–330 (2007).
Raucci, U. et al. Cyclic vomiting syndrome in children. Front. Neurol. 11, 583425 (2020).
Ye, Z., Xue, A., Huang, Y. & Wu, Q. Children with cyclic vomiting syndrome: phenotypes, disease burden and mitochondrial DNA analysis. BMC Gastroenterol. 18, 104 (2018).
Boles, R. G., Chun, N., Senadheera, D. & Wong, L. J. Cyclic vomiting syndrome and mitochondrial DNA mutations. Lancet 350, 1299–1300 (1997).
Salpietro, C. D., Briuglia, S., Merlino, M. V., Di Bella, C. & Rigoli, L. A mitochondrial DNA mutation (A3243G mtDNA) in a family with cyclic vomiting. Eur J Pediatr 162, 727–728 (2003).
Venkatesan, T. et al. Quantitative pedigree analysis and mitochondrial DNA sequence variants in adults with cyclic vomiting syndrome. BMC Gastroenterol. 14, 181 (2014).
Lee, J., Wong, S. A., Li, B. U. & Boles, R. G. NextGen nuclear DNA sequencing in cyclic vomiting syndrome reveals a significant association with the stress-induced calcium channel (RYR2). Neurogastroenterol. Motil. 27, 990–996 (2015).
Domingo, D. et al. Non-ventricular, clinical, and functional features of the RyR2(R420Q) mutation causing catecholaminergic polymorphic ventricular tachycardia. Rev. Esp. Cardiol. 68, 398–407 (2015).
O’Donnell, A. M., Nakamura, H. & Puri, P. Altered ryanodine receptor gene expression in Hirschsprung’s disease. Pediatr. Surg. Int. 35, 923–927 (2019).
Ellingsen, D. M. et al. Cyclic vomiting syndrome is characterised by altered functional brain imaging connectivity of the insular cortex: a cross comparison with migraine and healthy adults. Neurogastroenterol. Motil. 29, e13004 (2017).
Venkatesan, T. et al. Role of chronic cannabis use: cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome. Neurogastroenterol. Motil. 31, e13606 (2019).
Wasilewski, A. et al. Cannabinoid receptor type 1 and mu-opioid receptor polymorphisms are associated with cyclic vomiting syndrome. Am. J. Gastroenterol. 112, 933–939 (2017).
Fitzpatrick, E., Bourke, B., Drumm, B. & Rowland, M. Outcome of children with cyclical vomiting syndrome. Arch. Dis. Child. 92, 1001–1004 (2007).
Dignan, F., Symon, D. N. K., Abu-Arafeh, I. & Russel, L. G. The prognosis of cyclical vomiting syndrome. Arch. Dis. Child. 84, 55–57 (2001).
Hikita, T. et al. Sumatriptan as a treatment of cyclic vomiting syndrome: a clinical trial. Cephalalgia 31, 504–507 (2010).
Gelfand, A. A. Migraine and childhood periodic syndrome in children and adolescents. Curr. Opin. Neurol. 26, 262–268 (2013).
Levinthal, D. J. The cyclic vomiting syndrome threshold: a framework for understanding pathogenesis and predicting successful treatments. Clin. Transl. Gastroenterol. 7, e198 (2016).
Hornby, P. J. Central neurocircuitry associated with emesis. Am. J. Med. 111, 106S–112S (2001).
Mani, J. & Madani, S. Pediatric abdominal migraine: current perspectives on a lesser known entity. Pediatric Health Med. Ther. 9, 47–58 (2018).
Cuvellier, J.-C. & Lepine, A. Childhood periodic syndrome. Pediatr. Neurol. 42, 1–11 (2010).
Gelfand, A. A. Episodic syndromes that may be associated with migraine: A.K.A. “the childhood periodic syndromes”. Headache 55, 1358–1364 (2015).
Lagman-Bartolome, A. M. & Lay, C. Pediatric migraine variants: a review of epidemiology, diagnosis, treatment and outcome. Curr. Neurol. Neurosci. Rep. 15, 34 (2015).
Gelfand, A. A. Episodic syndromes of childhood associated with migraine. Curr. Opin. Neurol. 31, 281–285 (2018).
Sohon, E. The unique demand of childhood migraine. Nature 586, S19–S21 (2020).
Khurshid, M. S. & Abu-Arafeh, I. Randomised controlled trials of preventive treatment of migraine in children: quality of evidence as assessed against IHS guidelines [abstract IHC-PO-386]. Cephalalgia 39(IS), 252 (2019).
Powers, S. W. et al. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N. Engl. J. Med. 376, 115–124 (2017).
Oskoui, M. et al. Practice guideline update summary: acute treatment of migraine in children and adolescents: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 93, 487–499 (2019).
Oskoui, M. et al. Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Headache 59, 1144–1157 (2019).
Author information
Authors and Affiliations
Contributions
I.A.-A. carried out the literature review, wrote the first draft, and edited and approved subsequent drafts. A.A.G. contributed to the literature review, added to the first draft, and edited and approved subsequent drafts.
Corresponding author
Ethics declarations
Competing interests
I.A.-A. is the Chairman of the Child and Adolescent Standing Committee of the International Headache Society, is a Chief Investigator for two clinical trials sponsored by Eli-Lilly and a Principal Investigator for a clinical trial sponsored by Amgen. A.A.G. has received consulting fees from Biohaven, has received honoraria from JAMA Neurology and UpToDate, and receives grant support from Amgen and the Duke Clinical Research Institute. She receives a stipend from the American Headache Society for her role as Editor of Headache. The spouse of A.A.G. reports research support (to UCSF) from Genentech for a clinical trial, honoraria for editorial work from Dynamed Plus, and personal compensation for medical legal consulting.
Additional information
Informed consent
The authors affirm that human research participants provided informed consent for publication of the video in Supplementary Video 1.
Peer review information
Nature Reviews Neurology thanks V. Guidetti, F. Heinen, A. Verrotti and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Review criteria
In preparing this Perspective, literature searches of PubMed and Google Scholar were carried out to assess original research on components of the migraine syndrome. It was not the intention to perform a formal systematic review.
Supplementary information
Supplementary video 1
A child with a typical episode of benign paroxysmal torticollis.
Glossary
- Biopsychosocial model
-
A model in which the interaction of biological, psychological and social factors influence the presentation of disease and response to treatment.
- Cephalic cutaneous allodynia
-
An abnormal perception of normally innocuous sensory stimuli, such as combing of hair, as painful.
- Macropsia
-
A visual hallucination in which objects looks larger than their real size.
- Micropsia
-
A visual illusion in which objects looks smaller than their real size.
Rights and permissions
About this article
Cite this article
Abu-Arafeh, I., Gelfand, A.A. The childhood migraine syndrome. Nat Rev Neurol 17, 449–458 (2021). https://doi.org/10.1038/s41582-021-00497-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-021-00497-6
- Springer Nature Limited